![](/img/cover-not-exists.png)
Patient‐reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose‐escalation study 1108
O'Donnell, Peter H., Arkenau, Hendrick Tobias, Sridhar, Srikala S., Ong, Michael, Drakaki, Alexandra, Spira, Alexander I., Zhang, Jingsong, Gordon, Michael S., Degboe, Arnold N., Gupta, Ashok K., MukhLanguage:
english
Journal:
Cancer
DOI:
10.1002/cncr.32532
Date:
October, 2019
File:
PDF, 1.33 MB
english, 2019